People: Cynosure Inc (CYNO.OQ)

CYNO.OQ on NASDAQ Stock Exchange Global Select Market

19.89USD
3:01pm EDT
Price Change (% chg)

$-0.20 (-1.00%)
Prev Close
$20.09
Open
$19.90
Day's High
$20.14
Day's Low
$19.69
Volume
83,191
Avg. Vol
74,494
52-wk High
$31.48
52-wk Low
$19.14

Search Stocks

Summary

Name Age Since Current Position

Michael Davin

56 2013 Chairman of the Board, Chief Executive Officer

Timothy Baker

53 2013 Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer

Douglas Delaney

47 2013 Executive Vice President - Worldwide Sales

William Flannery

68 2013 Director

Brian Barefoot

70 2011 Independent Director

Ettore Biagioni

55 2005 Independent Director

Marina Hatsopoulos

48 2008 Independent Director

Thomas Robinson

55 2005 Independent Director

Biographies

Name Description

Michael Davin

Mr. Michael R. Davin is Chairman of the Board, Chief Executive Officer of Cynosure Inc. He served as President of the Company. Mr. Davin has been our president and chief executive officer and a director since September 2003, and became the chairman of its board of directors in October 2004. Mr. Davin has over 25 years of experience in the light-based technology field. From 1998 to 2003, Mr. Davin served as co-founder and vice president of worldwide sales and strategic development of Cutera, a provider of laser and other light-based aesthetic treatment systems.Prior to co-founding Cutera, Mr. Davin spent 11 years at Coherent Medical, a manufacturer of laser, optics and related equipment, in senior management positions in sales, marketing and clinical development. Mr. Davin has qualifications to serve on our board of directors include his two decades of experience in the light-based technology industry, including more than10 years as our president and chief executive officer.

Timothy Baker

Mr. Timothy W. Baker is Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer of Cynosure Inc. He is Chief Operating Officer of the Company since June 24, 2013. Mr. Baker has been the executive vice president, chief financial officer and treasurer since March 2004. From July 2003 to February 2004, Mr. Baker served as vice president, finance of Stryker Biotech, a division of Stryker Corporation, a medical products and services provider. From July 2000 to June 2003, Mr. Baker served as president and chief financial officer of Photoelectron Corp., a provider of miniature x-ray systems for radiation therapy. From January 1996 to July 2000, Mr. Baker served as the chief financial officer and vice president of operations of Radionics, Inc., a provider of surgical devices. Mr. Baker is a certified public accountant and holds an M.B.A. in operations management.

Douglas Delaney

Mr. Douglas J. Delaney is Executive Vice President - Worldwide Sales of Cynosure Inc. In June 2013, Mr. Delaney became our executive vice president of worldwide sales. Mr. Delaney has worked in medical laser sales for more than 16 years. From February 2005 through June 2013, Mr. Delaney was our executive vice president of sales. From 2004 until 2005, Mr. Delaney was our vice president, North American sales, and from 2003 until 2004, he was our director of North American sales. From 1999 to 2003, Mr. Delaney served as national sales manager of Cutera.

William Flannery

Mr. William O. Flannery is Director of Cynosure Inc.

Brian Barefoot

Mr. Brian M. Barefoot is the Independent Director of Cynosure Inc., since 2011. From 2001 to 2008, Mr. Barefoot served as Babson College president. From 1996 to 2001, Mr. Barefoot served as chairman of the board of trustees of Babson College. Mr. Barefoot serves on the boards of directors of Blue Cross Blue Shield of Massachusetts, where he is chair of the finance and business performance committee and a member of the audit committee. Mr. Barefoot serves as a director of Array Health Solutions, a health care technology and services company, and he is a senior advisor to Carl Marks Advisory Group LLC, a New York-based middle market merchant bank. Mr. Barefoot also serves as a director of BigBelly Solar, a Newton, Massachusetts solar energy company, and he serves as a director and chairman of the audit committee of the Indian River Medical Center Foundation. Mr. Barefoot also serves as trustee and vice chair of board of Saint Edwards School in Florida and as trustee of the Burr and Burton Academy in Vermont. Mr. Barefoot has qualifications to serve on our board of directors include his corporate governance experience combined with his leadership skills and experience derived from more than three decades in financial services.

Ettore Biagioni

Mr. Ettore V. Biagioni is the Independent Director of Cynosure Inc. He has been a director since 2005. Since 2004, Mr. Biagioni has been a managing partner of Alothon Group LLC, a private equity firm which he co-founded. From 1998 to 2004, Mr. Biagioni served as head of the Latin America Private Equity Group of Deutsche Bank/Bankers Trust Company. Mr. Biagioni serves on the boards of directors of several private companies. Mr. Biagioni has qualifications to serve on our board of directors include his experience serving as a director for other companies, which enhances his contributions to our board. In addition, his leadership skills and financial experience enable him to be an effective board member.

Marina Hatsopoulos

Ms. Marina Hatsopoulos is Independent Director of Cynosure Inc., since November 2008. Ms. Hatsopoulos has been a private investor since September 2007. Since 2008, she has been the president of Windy Street, Inc., a technology investment company, and since 2012, Ms. Hatsopoulos has been the chairman of the board of Levitronix Technologies LLC, a supplier of magnetically-levitated pumps. Also beginning in 2012, Ms. Hatsopoulos has been a director of Dear Kate, Inc., a supplier of women performance apparel. From August 2005 to September 2007, she was a director of Contex Holdings, a leading manufacturer of large-format scanners. From December 1994 to August 2005, she served as chief executive officer and director of Z Corporation, a leader in the 3D printing market, which was sold to Contex Scanning Technology in 2005. From 2005 through 2010, Ms. Hatsopoulos served as a director of the GSI Group, a supplier of precision technology to the global medical, electronics and industrial markets and semiconductor systems. From 2007 through its sale to Sara Lee in 2011, Ms. Hatsopoulos was as a director and investor of Tea Forte, a supplier of luxury tea products. Ms. Hatsopoulos is a catalyst at the Deshpande Center for Technological Innovation at MIT. Ms. Hatsopoulos has experience serving as a director and advisor for both public and private companies, which enhances her contributions to our board. Her leadership skills and experience with her own company and on other boards enable her to be an effective board member.

Thomas Robinson

Mr. Thomas H. Robinson is Independent Director of Cynosure Inc., since 2005. Since September 2011, Mr. Robinson has served as a partner with RobinsonButler, an executive search firm. During 2010, Mr. Robinson served as managing director at Russell Reynolds Associates. From 1998 to 2010, Mr. Robinson served as managing partner of the North American medical technology practice, which includes the medical device, hospital supply/distribution and medical software areas, of Spencer Stuart, Inc., a global executive search firm. From 2002 to 2010, Mr. Robinson was a member of Spencer Stuarts board services practice, which assists corporations to identify and recruit outside directors. From 1998 to 2000, Mr. Robinson headed Spencer Stuarts North American biotechnology specialty practice. From 1993 to 1997, Mr. Robinson served as president of the emerging markets business at Boston Scientific Corporation, a global medical devices manufacturer. From 1991 to 1993, Mr. Robinson also served as president and chief operating officer of Brunswick Biomedical, a cardiology medical device company. Mr. Robinson is a director of SANUWAVE Health, a publicly-traded regenerative medicine company. Mr. Robinson has qualifications to serve on our board of directors include his experience in and knowledge of the medical technology industry, combined with his operational and corporate governance experience.

Basic Compensation

Name Fiscal Year Total

Michael Davin

3,456,580

Timothy Baker

2,208,620

Douglas Delaney

1,845,020

William Flannery

--

Brian Barefoot

--

Ettore Biagioni

--

Marina Hatsopoulos

--

Thomas Robinson

--
As Of 30 Dec 2013

Options Compensation

Name Options Value

Michael Davin

642,336 11,291,600

Timothy Baker

343,681 6,024,005

Douglas Delaney

360,943 6,333,520

William Flannery

0 0

Brian Barefoot

0 0

Ettore Biagioni

0 0

Marina Hatsopoulos

0 0

Thomas Robinson

0 0
Search Stocks